3.37
price down icon3.16%   -0.11
after-market 시간 외 거래: 3.40 0.03 +0.89%
loading
전일 마감가:
$3.48
열려 있는:
$3.49
하루 거래량:
444.43K
Relative Volume:
3.42
시가총액:
$127.30M
수익:
-
순이익/손실:
$-27.66M
주가수익비율:
-3.5474
EPS:
-0.95
순현금흐름:
$-24.36M
1주 성능:
+1.20%
1개월 성능:
-4.53%
6개월 성능:
-11.32%
1년 성능:
+19.08%
1일 변동 폭
Value
$3.36
$3.55
1주일 범위
Value
$3.30
$3.6049
52주 변동 폭
Value
$1.95
$5.885

Genelux Corp Stock (GNLX) Company Profile

Name
명칭
Genelux Corp
Name
전화
805-267-9889
Name
주소
2625 TOWNSGATE ROAD, SUITE 230, WESTLAKE VILLAGE
Name
직원
24
Name
트위터
Name
다음 수익 날짜
Name
최신 SEC 제출 서류
Name
GNLX's Discussions on Twitter

GNLX을(를) 다른 주식과 비교

주식 가격 시가총액 매출 순이익 현금흐름 주당 순 이익
Biotechnology icon
GNLX
Genelux Corp
3.37 131.45M 0 -27.66M -24.36M -0.95
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
396.12 101.77B 11.39B 3.64B 3.50B 13.99
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
573.38 60.12B 14.21B 4.46B 3.56B 39.68
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
452.00 59.45B 2.46B -319.09M -52.09M -2.47
Biotechnology icon
ARGX
Argen X Se Adr
750.78 44.90B 3.06B 1.28B 447.35M 21.30
Biotechnology icon
ONC
Beone Medicines Ltd Adr
341.80 35.07B 3.81B -644.79M -669.77M -6.24

Genelux Corp Stock (GNLX) Upgrades & Downgrades

날짜 액션 분석자 등급 변경
2024-10-29 개시 Guggenheim Buy
2024-08-28 개시 ROTH MKM Buy
2023-11-27 개시 H.C. Wainwright Buy
2023-09-12 개시 Maxim Group Buy
2023-02-15 개시 The Benchmark Company Speculative Buy

Genelux Corp 주식(GNLX)의 최신 뉴스

pulisher
09:24 AM

Does Genelux Corporation show high probability of rebound2025 Momentum Check & High Accuracy Investment Signals - Newser

09:24 AM
pulisher
Sep 05, 2025

Is Genelux Corporation forming a bullish divergence2025 Institutional Moves & Capital Protection Trade Alerts - خودرو بانک

Sep 05, 2025
pulisher
Sep 05, 2025

Is Genelux Corporation still worth holding after the dip2025 Analyst Calls & Weekly Watchlist of Top Performers - Newser

Sep 05, 2025
pulisher
Sep 05, 2025

Full technical analysis of Genelux Corporation stockSwing Trade & Daily Stock Trend Reports - Newser

Sep 05, 2025
pulisher
Sep 05, 2025

Genelux Corporation stock daily chart insightsMarket Activity Summary & Breakout Confirmation Alerts - Newser

Sep 05, 2025
pulisher
Sep 05, 2025

Charles Schwab Investment Management Inc. Purchases New Shares in Genelux Corporation $GNLX - Defense World

Sep 05, 2025
pulisher
Sep 04, 2025

Is Genelux Corporation a top pick in the sectorQuarterly Growth Report & Growth Focused Investment Plans - خودرو بانک

Sep 04, 2025
pulisher
Sep 03, 2025

S P Trends: What are the risks of holding Genelux CorporationQuarterly Trade Review & AI Enhanced Trading Alerts - خودرو بانک

Sep 03, 2025
pulisher
Sep 03, 2025

Genelux Corp. Lowers Stock Option Exercise Prices - TipRanks

Sep 03, 2025
pulisher
Sep 03, 2025

What is Genelux Corporation s revenue forecastWeekly Profit Summary & Safe Capital Growth Plans - خودرو بانک

Sep 03, 2025
pulisher
Sep 03, 2025

Using flow based indicators on Genelux CorporationJuly 2025 Weekly Recap & Free Safe Entry Trade Signal Reports - Newser

Sep 03, 2025
pulisher
Sep 03, 2025

Can a trend reversal in Genelux Corporation lead to recoveryJuly 2025 Fed Impact & Consistent Profit Alerts - Newser

Sep 03, 2025
pulisher
Sep 03, 2025

Tools to monitor Genelux Corporation recovery probabilityTrend Reversal & Expert Approved Momentum Ideas - Newser

Sep 03, 2025
pulisher
Sep 02, 2025

Immuno-Oncology Pioneer Genelux Leadership Team Featured at H.C. Wainwright Global Investment Conference - Stock Titan

Sep 02, 2025
pulisher
Sep 02, 2025

How to interpret RSI for Genelux Corporation stockJuly 2025 Setups & Verified Momentum Stock Watchlist - Newser

Sep 02, 2025
pulisher
Sep 01, 2025

Is a relief rally coming for Genelux Corporation holdersMarket Activity Report & Fast Moving Stock Watchlists - Newser

Sep 01, 2025
pulisher
Sep 01, 2025

Is Gores Holdings IX Inc. Equity Warrant exposed to political riskPortfolio Gains Report & Free Weekly Watchlist of Top Performers - خودرو بانک

Sep 01, 2025
pulisher
Sep 01, 2025

Oncolytic Virus Cancer Therapy Pipeline Outlook 2025: Clinical Trial Studies, EMA, PDMA, FDA Approvals, MOA, ROA, NDA, IND, and Companies - The Globe and Mail

Sep 01, 2025
pulisher
Aug 31, 2025

What institutional flow reveals about Genelux CorporationWeekly Investment Recap & Reliable Breakout Forecasts - Newser

Aug 31, 2025
pulisher
Aug 31, 2025

Leading vs lagging indicators on Genelux Corporation performancePortfolio Profit Report & Growth Oriented Trade Recommendations - Newser

Aug 31, 2025
pulisher
Aug 31, 2025

Genelux Corporation Stock Approaches Key Moving Average2025 Big Picture & Daily Price Action Insights - beatles.ru

Aug 31, 2025
pulisher
Aug 31, 2025

Technical analysis overview for Genelux Corporation stockJuly 2025 Sector Moves & Stepwise Entry/Exit Trade Alerts - Newser

Aug 31, 2025
pulisher
Aug 31, 2025

Using Bollinger Bands to evaluate Genelux CorporationWeekly Stock Summary & Verified Entry Point Signals - Newser

Aug 31, 2025
pulisher
Aug 31, 2025

Genelux Corporation stock prediction for this week2025 Short Interest & Advanced Swing Trade Entry Plans - Newser

Aug 31, 2025
pulisher
Aug 31, 2025

Published on: 2025-08-30 23:56:19 - Newser

Aug 31, 2025
pulisher
Aug 30, 2025

Why Genelux Corporation is moving todayMarket Performance Report & Verified Stock Trade Ideas - Newser

Aug 30, 2025
pulisher
Aug 30, 2025

Real time scanner hits for Coterra Energy Inc. explainedWeekly Trend Summary & Community Trade Idea Sharing Platform - Newser

Aug 30, 2025
pulisher
Aug 30, 2025

Is now a turning point for Genelux Corporation2025 Investor Takeaways & Safe Investment Capital Preservation Plans - Newser

Aug 30, 2025
pulisher
Aug 30, 2025

Is Genelux Corporation showing signs of accumulationOil Prices & Capital Protection Trade Alerts - Newser

Aug 30, 2025
pulisher
Aug 29, 2025

Applying Wyckoff theory to Genelux Corporation stock2025 Geopolitical Influence & Advanced Swing Trade Entry Plans - Newser

Aug 29, 2025
pulisher
Aug 29, 2025

What recovery options are there for Genelux CorporationPortfolio Gains Report & Daily Risk Controlled Trade Plans - Newser

Aug 29, 2025

Genelux Corp (GNLX) 재무 분석

매출

loading

순이익

loading

현금흐름

loading

주당 순 이익

loading

Genelux Corp 주식 (GNLX) 내부자 거래

내부자 거래 관계 날짜 거래 비용 #주식 가치 ($) #주식 총계
Zindrick Thomas
President and CEO
May 12 '25
Sale
2.92
10,764
31,431
191,447
Yu Yong
VP, Clinical Trial Operations
May 12 '25
Sale
2.92
5,579
16,291
47,640
Cappello Joseph
VP, Pharmaceutical Development
May 12 '25
Sale
2.92
4,737
13,832
52,266
Smalling Ralph
Head of Regulatory
May 12 '25
Sale
2.92
1,259
3,676
34,760
Tyree James L
Director
Dec 30 '24
Sale
2.46
3,460
8,512
45,791
$86.64
price up icon 1.40%
$27.54
price up icon 0.58%
$25.98
price up icon 9.16%
$112.46
price up icon 8.66%
$145.10
price up icon 1.80%
biotechnology ONC
$341.80
price up icon 7.24%
자본화:     |  볼륨(24시간):